Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol

Molecular Biology of the Cell

Volumn 14, Issue 1, 2003, Pages 334-347

  Labrecque, Lyne ^a   Royal, Isabelle ^a   Surprenant, David S ^a   Patterson, Cam ^b   Gingras, Denis ^a   Béliveau, Richard ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CHOLESTEROL; PROTEIN TYROSINE KINASE; TYROSINE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAVEOLA; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DISSOCIATION; EMBRYO; ENDOTHELIUM; GENE ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIPID MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING;

CAVEOLIN 1; CAVEOLINS; CELL MEMBRANE; CHOLESTEROL; HUMANS; OLIGOPEPTIDES; PHOSPHORYLATION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TYROSINE;

ANIMALIA;

EID: 0037237791     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-07-0379     Document Type: Article

References (82)

1. Abedi, H., and Zachary, I. (1997). Vascular endothelial growth factor stimulates tvrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem., 272, 15443-15451.
2. Abu-Ghazaleh, R., Kabir, J., Jia, H., Lobo, M., and Zachary, I. (2001). Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem. J. 360, 255-264.
3. Anderson, R.G.W. (1998). The caveolae membrane system. Annu. Rev. Biochem., 67, 199-225.
4. Borges, E., Jan, Y., and Ruoslahti, E. (2000). PDGF-receptor-b and VEGF-receptor-2 bind to the β-3 integrin through its extracellular domain. J. Biol. Chem. 275, 39867-39873.
5. Brown, J., Reading, S.J., Jones, S., Fitchett, C.J., Howl, J., Martin, A., Longland, C.L., Michelangeli, F., Dubrova, Y.E., and Brown, C.A. (2000). Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab. Invest. 80, 37-45.
6. Brown, M.T., and Cooper, J.A. (1996). Regulation, substrates and functions of src. Biochem. Biophys. Acta 1287, 121-149.
7. Cao, H., Courchesne, W.E., and Mastick, C.C. (2002). A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine14: recruitment of C-terminal Src kinase. J. Biol. Chem. 277, 8771-8774.
8. r protein-tyrosine phosphatase. J. Biol. Chem. 276, 18849-18854.
9. Chang, W.-J., Rothberg, K.G., Kamen, B.A., and Anderson, R.G.W. (1992). Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J. Cell Biol. 118, 63-69.
10. Couet, J., Li, S., Okamoto, T., Ikezu, T., and Lisanti, M.P. (1997a). Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272, 6525-6533.
11. Couet, J., Sargiacomo, M., and Lisanti, M.P. (1997b). Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272, 30429-30438.
12. Demeule, M., Jodoin, J., Gingras, D., and Béliveau, R. (2000). P-Glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett. 466, 219-224.
13. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F.C., Schedl, A., Haller, H., and Kurzchalia, T.V. (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452.
14. Eliceiri, B.P., Paul, R., Schwartzberg, P.L., Hood, J.D., Leng, J., and Cheresh, D.A. (1999). Selective requirement for src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4, 915-924.
15. Eliceiri, B.P., Puente, X.S., Hood, J.D., Stupack, D.G., Schlaepfer, D.D., Huang, X.Z., Sheppard, D., and Cheresh, D.A. (2002). Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling. J. Cell Biol. 157, 149-160.
16. Engelman, J.A., Lee, R.J., Karnezis, A., Bearss, D.J., Webster, M., Siegel, P., Muller, W.J., Windle, J.J., Pestell, R.G., and Lisanti, M.P. (1998). Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vivo and in vitro. Implications for human breast cancer. J. Biol. Chem. 273, 20448-20455.
17. Engelman, J.A., Zhang, X.L., and Lisanti, M.P. (1999). Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett. 48, 221-230.
18. Erpel, T., and Courtneidge, S.A. (1995). Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7, 176-182.
19. Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T., and Risau, W. (1998). Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140, 947-959.
20. Feng, Y., Venema, V.J., Venema, R.C., Tsai, N., Behzadian, M.A., and Caldwell, R.B. (1999b). VEGF-induced permeability increase is mediated by caveolae. Invest. Ophthal. Vis. Sci. 40, 157-167.
21. Feng, Y., Venema, V.J., Venema, R.C., Tsai, N., and Caldwell, R.B. (1999a). VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem. Biophys. Res. Commun. 256, 192-197.
22. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 149-153.
23. Fuh, G., Li, B., Crowley, C., Cunningham, B., and Wells, J.A. (1998). Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J. Biol. Chem. 273, 11197-11204.
24. Fujioka, K., Azuma, N., Kito, H., Gahtan, V., Esato, K., and Sumpio, B.E. (2000). Role of caveolin in hemodynamic force-mediated endothelial changes. J. Surg. Res. 92, 7-10.
25. Furuchi, T., and Anderson, R.G.W. (1998). Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273, 21099-21104.
26. Galbiati, F., Volonte, D., Engelman, J.A., Watanabe, G., Burk, R., Pestell, R.G., and Lisanti, M.P. (1998). Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17, 6633-6648.
27. Gerbert, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/ KDR activation. J. Biol. Chem. 273, 30336-30343.
28. Gingras, D., Gauthier, F., Lamy, S., Desrosiers, R.R., and Béliveau, R. (1998). Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains. Biochem. Biophys. Res. Commun. 247, 888-893.
29. Gingras, D., Lamy, S., and Béliveau, R. (2000). Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins. Biochem. J. 348, 272-280.
30. Gitay-Goren, H., Soker, S., Vlodavsky, I., and Neufeld, G. (1992). The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098.
31. Griffoni, C., Spisni, E., Santi, S., Riccio, M., Guarnieri, T., and Tomasi, V. (2000). Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 276, 756-761.
32. Guo, D., Jia, Q., Song, H.-Y., Warren, R.S., and Donner, D.B. (1995). Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270, 6729-6733.
33. Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
34. He, H., Venema, V.J., Gu, X., Venema, R.C., Marrero, M.B., and Caldwell, R.B. (1999). Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin throughout Flk-1/KDR activation of c-src. J. Biol. Chem. 274, 25130-25135.
35. Kim, Y.N., Wiepz, G.J., Guadarrama, A.G., and Bertics, P.J. (2000). Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status. J. Biol. Chem. 275, 7481-7491.
36. Koleske, A.J., Baltimore, D., and Lisanti, M.P. (1995). Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92, 1381-1385.
37. Kroll, J., and Waltenberger, J. (1997). The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem. 272, 32521-32527.
38. Lee, H., Volonte, D., Galbiati, F., Iyengar, P., Lublin, D.M., Bregman, D.B., Wilson, M.T., Campos-Gonzalez, R., Bouzahzah, B., Pestell, R.G., Scherer, P.E., and Lisanti, M.P. (2000). Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol. Endocrinol. 14, 1750-1775.
39. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J.E., Hansen, S.H., Nishimoto, I., and Lisanti, M.P. (1995). Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270, 15693-15701.
40. Li, S., Seitz, R., and Lisanti, M.P. (1996). Phosphorylation of caveolin by src tyrosine kinases. The α-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem. 271, 3863-3868.
41. Liu, J., Razani, B., Tang, S., Terman, B.I., Ware, J.A., and Lisanti, M.P. (1999). Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J. Biol. Chem. 274, 15781-15785.
42. Liu, J., Wang, X.B., Park, D.S., and Lisanti, M.P. (2002). Caveolin-1 expression enhances endothelial capillary tubule formation. J. Biol. Chem. 277, 10661-10668.
43. Liu, J., Ying, Y., and Anderson, R.G.W. (1997). Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc. Natl. Acad. Sci. USA 94, 13666-13670.
44. Liu, P., Ying, Y., Ko, Y.G., and Anderson, R.G.W. (1996). Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271, 10299-10303.
45. Mastick, C.C., Brady, M.J., and Saltiel, A.R. (1995). Insulin stimulates the tyrosine phosphorylation of caveolin. J. Cell Biol. 129, 1523-1531.
46. Mastick, C.C., and Saltiel, A.R. (1997). Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J. Biol. Chem. 272, 20706-20714.
47. Matsumoto, T., and Claesson-Welsh, L. (2001). VEGF receptor signal transduction. Sci. STKE 2001, RE21.
48. Mendel, D.B., Laird, A.D., Smolich, B.D., Blake, R.A., Liang, C., Hannah, A.L., Shaheen, R.M., Ellis, L.M., Weitman, S., Shawver, L.K., and Cherrington, J.M. (2000). Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anticancer Drug Des. 15, 29-41.
49. Mineo, C., Gill, G.N., and Anderson, R.G.W. (1999). Regulated migration of epidermal growth factor receptor from caveolae. J. Biol. Chem. 274, 30636-30643.
50. Mineo, C., James, G.L., Smart, E.J., and Anderson, R.G.W. (1996). Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem. 271, 11930-11935.
51. Nomura, R., and Fujimoto, T. (1999). Tyrosine-phosphorylated caveolin-1: immunolocalization and molecular characterization. Mol. Biol. Cell 10, 975-986.
52. Oh, P., and Schnitzer, J.E. (2001). Segregation of heterotrimeric G protein in cell surface microdomains. Mol. Biol. Cell 12, 685-698.
53. Papapetropoulos, A., Garcîa-Cardena, G., Madri, J.A., and Sessa, W.C. (1997). Nitric oxide production contributes to the angigenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100, 3131-3139.
54. Parenti, A., Morbidelli, L., Cui, X.L., Douglas, J.G., Hood, J.G., Granger, H.J., Ledda, F., and Ziche, M. (1998). Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 273, 4220-4226.
55. Parpal, S., Karlsson, M., Thorn, H., and Stralfors, P. (2001). Cholesterol depletion disrupts caveolae and insulin receptor signaling formetabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J. Biol. Chem. 276, 9670-9678.
56. Patterson, C., Perrella, M.A., Hsieh, C.M., Yoshizumi, M., Lee, M.E., and Haber, E. (1995). Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J. Biol. Chem. 270, 23111-23118.
57. Pol, A., Calvo, M., and Enrich, C. (1998). Isolated endosomes from quiescent rat liver contain the signal transduction machinery. Differential distribution of activated Raf-1 and Mek in the endocytic compartment. FEBS Lett. 441, 34-38.
58. Pol, A., Lu, A., Pons, M., Peiro, S., and Enrich, C. (2000). Epidermal growth factor-mediated caveolin recruitment to early endosomes and MAPK activation. Role of cholesterol and actin cytoskeleton. J. Biol. Chem. 275, 30566-30572.
59. Razani, B., Engelman, J.A., Wang, X.B., Schubert, W., Zhang, X.L., Marks, C.B., Macaluso, F., Russell, R.G., Li, M., Pestell, R.G., Di Vizio, D., Hou, H., Jr., Kneitz, B., Lagaud, G., Christ, G.J., Edelmann, W., and Lisanti MP. (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138.
60. Rodal, S.K., Skretting, G., Garred, O., Vilhardt, F., van Deurs, B., and Sandvig, K. (1999). Extraction of cholesterol with methyl-b-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10, 961-974.
61. Rothberg, K.G., Heuser, J.E., Donzell, W.C., Ying, Y.-S., Glenney, J.R., and Anderson, R.G.W. (1992). Caveolin, a protein component of caveolae membrane coats. Cell 68, 673-682.
62. Rousseau, S., Houle, F., Kotanides, H., Witte, L., Waltenberger, J., Landry, J., and Huot, J. (2000). Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J. Biol. Chem., 10661-10672.
63. Schlaeppi, J.M., and Wood, J.M. (1999). Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosinekinase inhibitors. Cancer Metastasis Rev. 18, 473-481.
64. Schlegel, A., and Lisanti, M.P. (2000a). A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 c-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J. Biol. Chem. 275, 21605-21617.
65. Schlegel, A., Pestell, R.G., and Lisanti, M.P. (2000b). Caveolins in cholesterol trafficking and signal transduction: implications for human disease. Front. Biosci. 5, D929-D937.
66. Schnitzer, J.E., Oh, P., Pinney, E., and Allard, J. (1994). Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127, 1217-1232.
67. Smart, E.J., Ying, Y., Donzell, W.C., and Anderson, R.G.W. (1996). A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271, 29427-29435.
68. Smart, E.J., Ying, Y.-S., Mineo, C., and Anderson, R.G.W. (1995). A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc. Natl. Acad. Sci. USA 92, 10104-10108.
69. Song, K.S., Li, S., Okamoto, T., Quilliam, L.A., Sargiacomo, M., and Lisanti, M.P. (1996). Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem. 271, 9690-9697.
70. Suda, K., Rothen-Rutishausser, B., Gunthert, M., and Wunderli-Allenspach, H. (2001). Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev. Biol. Anim. 37, 505-514.
71. Thomas, K.A. (1996). Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271, 603-606.
72. Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P., and Malik, A.B. (1997). Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J. Biol. Chem. 272, 25968-25975.
73. Ushio-Fukai, M., Hilenski, L., Santanam, N., Becker, P.L., Ma, Y., Griendling, K.K., and Alexander, R.W. (2001). Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells. role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J. Biol. Chem. 276, 48269-48275.
74. Vincent, L., Chen, W., Hong, L., Mirshahi, F., Mishal, Z., Mirshahi-Khorassani, T., Vannier, J.P., Soria, J., and Soria, C. (2001). Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett. 495, 159-166.
75. Volonte, D., Galbiati, F., Pestell, R.G., and Lisanti, M.P. (2001). Cellular stress induces the tyrosine phosphorylation of caveolin-1(Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J. Biol. Chem. 276, 8094-8103.
76. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C.H. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995.
77. Wary, K.K., Mariotti, A., Zurzolo, C., and Giancotti, F.G. (1998). A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94, 625-634.
78. Wiechen, K., Sers, C., Agoulnik, A., Arlt, K., Dietel, M., Schlag, P.M., and Schneider, U. (2001). Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol. 158, 833-839.
79. Wigler, M., Pellicer, A., Silverstein, R., Axel, R., Urlaub, G., and Chasin, L. (1979). DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. USA 76, 1373-1376.
80. Xia, P., Aiello, L.P., Ishii, H., Jiang, Z.Y., Park, D.J., Robinson, G.S., Takagi, H., Newsome, W.P., Jirousek, M.R., and King, G.L. (1996). Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 98, 2018-2026.
81. Yamamoto, M., Toya, Y., Jensen, R.A., and Ishikawa, Y. (1999). Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp. Cell Res. 247, 380-388.
82. Zhang, W., Razani, B., Altschuler, Y., Bouzahzah, B., Mostov, K.E., Pestell, R.G., and Lisanti, M.P. (2000). Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J. Biol. Chem. 275, 20717-20725.